Register Now
Course Information

Biologics Therapies Summit IX:
Rheumatic and Immunologic Diseases Through the Lens of COVID-19 and Specific Questions in Vasculitis Treatment for 2021: Approach, Agent, Dose, Duration Virtual Symposium

Overview

In appreciation for caregivers’ sacrifice and dedication, for the FIRST time, we are offering this 2021 virtual CME completely free. While the registration fee has changed, our standard for advanced, high-quality content and renowned faculty remains the same

Objectives

By attending, participants will be able to:

  • Discuss factors that influence the selection of treatments for vasculitis disorders.
  • Outline how data on the efficacy and side effect profiles for different vasculitis therapies impact decisions for choice of agent, dose, and duration.
  • Describe the evidence base supporting diverse therapies for ANCA-associated vasculitis, including rituximab, conventional immunosuppressive agents, glucocorticoids, and plasma exchange.
  • Summarize evidence on COVID-19: vaccinations, cytokine storm, and effects on patients with autoimmune disease, and describe the implications for clinical practice.
  • Define the current status of targeted therapies, especially anti-TNF, anti-IL17, IL-23, and JAK inhibitors, in rheumatoid arthritis and spondyloarthritis.
  • Assess the clinical impact of recent evidence on treatment of patients with immune-mediated inflammatory diseases including vaccines, COVID-19, and targeted therapies.
  • Describe strategies for preventing infectious complications associated with immune-mediated inflammatory diseases.

Why Attend?

  • Hear from renowned experts in rheumatology and immunology
  • Understand new approaches to diagnosis and treatment of immune-based inflammatory diseases
  • Receive access to the live stream recordings after the course
  • Live Q&A panel discussions to supplement the virtual presentations
  • Easy access - participate at your convenience from any location
  • FREE registration!

Who Should Attend?

The Summit is directed to rheumatologists, dermatologists, infectious disease physicians, allergists, clinical immunologists, as well as specialists in integrative medicine, preventive medicine, wellness, primary care, and other health care professionals caring for patients with vasculitis and immune-mediated inflammatory diseases.